Superstring Capital Management LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $151 Billion distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $19.6B, Nkarta, Inc. with a value of $12.9B, 89bio, Inc. with a value of $11B, Bridge Bio Pharma, Inc. with a value of $10.9B, and Savara Inc with a value of $10.3B.
Examining the 13F form we can see an increase of $11.1B in the current position value, from $140B to 151B.
Superstring Capital Management LP is based out at New York, NY
Below you can find more details about Superstring Capital Management LP portfolio as well as his latest detailed transactions.